ADAMTS9 and gastric cancer: High expression of ADAMTS9-AS2 enhanced the sensitivity to cisplatin, which was mainly due to ADAMTS9-AS2 sponging miR-223-3p to promote the expression of NLRP3, thus promoting pyroptosis in gastric cancer cells [96].